Clinical Trial Update: Oral Anticoagulant Apixaban for Treatment of Venous Thromboembolism [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for oral anticoagulant apixaban in the treatment of venous thromboembolism has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• Apixaban (apixaban)

Snippet

Sponsor: New York Medical College | Conditions: Venous Thromboembolism | Phase 2 | Status: COMPLETED